DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,053 | -9.6% | 25,240 | +0.0% | 0.00% | -33.3% |
| Q2 2023 | $355,323 | +93160.6% | 25,236 | +2.3% | 0.00% | 0.0% |
| Q1 2023 | $381 | -12.0% | 24,670 | -6.6% | 0.00% | 0.0% |
| Q4 2022 | $433 | -99.9% | 26,418 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $479,000 | +38.0% | 26,418 | +0.1% | 0.00% | +33.3% |
| Q2 2022 | $347,000 | +41.6% | 26,380 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $245,000 | -8.2% | 26,380 | -16.8% | 0.00% | 0.0% |
| Q4 2021 | $267,000 | +394.4% | 31,692 | +1905.8% | 0.00% | – |
| Q3 2021 | $54,000 | -6.9% | 1,580 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | -20.5% | 1,580 | -3.1% | 0.00% | – |
| Q1 2021 | $73,000 | -21.5% | 1,630 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $93,000 | +19.2% | 1,630 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $78,000 | +239.1% | 1,530 | +302.6% | 0.00% | – |
| Q2 2020 | $23,000 | – | 380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |